Cardiovascular risk estimation in young patients with ankylosing spondylitis: A new model based on a prospective

Mihaela Ionescu1, Paris Ionescu1, Adrian Paul Suceveanu1

  • 1Department of Clinical Medical Sciences, Faculty of General Medicine, 'Ovidius' University of Constanta, 900527 Constanta, Romania.

Insights

The Systematic Coronary Risk Evaluation (SCORE) chart underestimates cardiovascular disease risk in young ankylosing spondylitis patients. A relative risk (RR) chart, especially with carotid ultrasound, offers better cardiovascular risk prediction in this population.

Area of Science:

  • Cardiology
  • Rheumatology
  • Public Health

Background:

  • Cardiovascular (CV) risk assessment is crucial for patient management.
  • Standard CV risk charts have limitations in special populations.
  • Ankylosing spondylitis (AS) patients may have underestimated CV risk.

Purpose of the Study:

  • To evaluate if the Systematic Coronary Risk Evaluation (SCORE) chart underestimates CV risk in young AS patients.
  • To highlight the need for improved CV risk assessment models for AS.
  • To compare the predictive value of SCORE and a relative risk (RR) chart using carotid plaque detection.

Main Methods:

  • Prospective study of 70 Romanian AS patients (≤50 years) without prior CV disease, diabetes, or CKD.
  • CV risk assessed using the SCORE chart and an RR chart (smoking, systolic BP, total cholesterol).
  • Carotid plaques detected via ultrasound; C-reactive protein (CRP) levels measured.

Main Results:

  • Most patients (65.71%) had low SCORE risk; none were high/very high risk.
  • Carotid plaques found in 21.74% of low-risk and 50% of moderate-risk SCORE patients.
  • ESC guidelines identified 22 patients (31.4%) at high/very high CV risk due to carotid plaques.
  • RR chart showed higher plaque prevalence with RR>1.
  • CRP >3 mg/dl associated with RR>1.

Conclusions:

  • The SCORE system significantly underestimates CV risk in young AS patients, particularly those with carotid plaques.
  • The RR chart, enhanced by carotid ultrasound and CRP levels, provides more accurate CV risk prediction in this population.
  • New, tailored risk assessment models are necessary for AS patients to prevent CV events.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
204
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
110
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
158
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
113
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
964
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
573